Prosecution Insights
Last updated: April 19, 2026

Foghorn Therapeutics Inc.

6 pending office actions

Portfolio Summary

6
Total Pending OAs
0
Final Rejections
6
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18519533 COMPOUNDS AND USES THEREOF COUGHLIN, MATTHEW P 1626 Non-Final OA Nov 27, 2023
18282279 THERAPEUTIC REGIMENS OF AN INHIBITOR OF THE ENZYMATIC ACTIVITY OF BRG1 AND BRM HEASLEY, MEGHAN CHRISTINE 1626 Non-Final OA Sep 15, 2023
18223443 CITRATE SALT, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME HABTE, KAHSAY 1624 Non-Final OA Jul 18, 2023
18253541 COMPOUNDS AND USES THEREOF BAUER, NICOLA MARIA 1621 Non-Final OA May 18, 2023
18252228 COMPOUNDS AND USES THEREOF AULAKH, CHARANJIT 1621 Non-Final OA May 09, 2023
17907463 COMPOUNDS AND USES THEREOF SAMSELL, RILLA MARIE 1624 Non-Final OA Sep 27, 2022

Managing Foghorn Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month